Illegal drug use during pregnancy is associated with a host of complications for both Mother and baby

The potential dangers of illegal drug use are never far from the media spotlight, and drug use during pregnancy may be associated with particular health problems both for the Mother and baby. Drug use during pregnancy has been linked with a number of negative outcomes, for example, cocaine use has [read the full story...]

Nature vs. nurture: the case of depression. How do your genetic make up and life experiences affect your chances of developing depression?

One of the first lectures I attended at Medical School was an introduction to the “nature vs. nurture” debate. I recall the general consensus was a bit of both, however it wasn’t until many years later and well into my public health career that I began to see the value [read the full story...]

Alcohol consumption accounted for 19,500 cancer deaths in the US in 2009

Alcohol, together with tobacco and obesity, is one of the most important modifiable causes of morbidity and premature mortality, and is estimated to account for around 4% of deaths worldwide. This study attempted to clarify the number of alcohol-attributable cancer deaths in the United States, and the years of potential [read the full story...]

The cardiovascular safety of dementia medications: a cross national study

Two of the most widely available medicines for dementia in the UK are cholinesterase inhibitors and a N-methyl-D-aspartate (NMDA) receptor antagonists (NHS, 2013).  Both drugs are popular because they have been found to lead to improvements in dementia symptoms (Raina 2008). However, some have raised concerns about the safety for [read the full story...]

Short-term recovery from mild cognitive impairment is possible, but an increased risk of further cognitive decline remains

The symptoms of mild cognitive impairment (MCI) include problems with cognitive functioning such as day-to-day memory. In some individuals it is the first sign of dementia, whereas in others it may be due to resolvable factors such as being the side-effect of medication (Alzheimer’s Society, 2012). At present it is [read the full story...]

Depression and bipolar disorder linked to an increased risk of developing dementia, says systematic review

Dementia and affective disorders (such as depression and bipolar disorder) are usually considered to be completely unrelated afflictions. Yet a number of recent studies have suggested that the risk of developing dementia in later life may be increased for those who have had an affective disorder. A number of systematic [read the full story...]

Neglect may be as harmful as physical and emotional abuse, according to new systematic review

According to the World Health Organisation (WHO), somewhere between 25 and 50% of people may have been physically abused at some point during their childhood, an experience defined as the use of physical force that harms the child’s health, survival, development, or dignity. Childhood maltreatment does not stop at physical [read the full story...]

The difference of a few weeks in the womb: do early-term infants have poorer developmental outcomes?

Human pregnancy is considered to be full-term when it lasts between 37-42 weeks. Anything shorter is considered to be a pre-term birth and anything longer is considered post-term. Longer pregnancies can be a risk to both the mother and infant and so labour tends to be induced if a pregnancy [read the full story...]

Systematic review finds that suicide risk for prisoners with bipolar disorder may be lower than other mental disorders

In prisons, suicide is the leading cause of mortality (estimated at 3-5 times the general population). Mental health disorders are known to increase the risk. Generally, suffering from a bipolar disorder increases the risk of attempted or completed suicide when compared to the general population. So it would be expected [read the full story...]

Meta-analysis shows a small increased risk of brain haemorrhage in people taking SSRIs

Depression is a serious mental health threat proclaimed to be the greatest disease burden in the industrialised world by 2020 (Simon, 2003). In the pharmaceutical combat against depression, selective serotonin reuptake inhibitors (SSRIs) are the current treatment of choice. Indeed, SSRIs are the most prescribed antidepressant medicine (Helms & Eric, 2006). As [read the full story...]

© 2011 The Mental Elf is brought to you by Minervation Ltd Suffusion theme by Sayontan Sinha